We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Stem Cells Derived by Parthenogenesis

By Biotechdaily staff writers
Posted on 21 May 2002
Specialized cell types, including heart and brain cells, have been developed from embryonic monkey stem cells through parthenogenesis by researchers at Advanced Cell Technology (ACT, Worcester, MA, USA) and Wake Forest University School of Medicine (Winston-Salem, NC, USA). More...
The research was reported in the January 31, 2002, issue of Science.

Pathenogenesis is a process by which embryonic development is initiated directly from an unfertilized egg cell, so no fetus develops. The process may avoid the controversy associated with using embryonic stem cells. The researchers generated a pluripotent stem cell line, from which they have produced neurons, heart muscle, smooth muscle, and other kinds of cells. The cell line has grown continuously for 10 months. Potential applications include the treatment of disease where specific cell types have become dysfunctional, such as heart disease, diabetes, and Parkinson's disease. Cells derived from this renewable source might be able to alleviate some technical problems of human cell therapy, say the researchers.

The most remarkable differentiation was the development of midbrain dopamine neurons. "This is a special population of neurons whose efficient generation from primate embryonic stem cells had not been reported previously,” noted Drs. Grant and Vrana, both professors of physiology and pharmacology at Wake Forest.





Related Links:
Univ. of Wake Forest
Advanced Cell Technology

New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Electrolyte Analyzer
BKE-B
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more

Pathology

view channel
Image: Study flowchart. This study developed a multimodal artificial intelligence framework to predict PIK3CA mutations in breast cancer (Jiaxian Miao et al., Cancer Biol Med 23(3): 430–450 (2026). DOI: 10.20892/j.issn.2095-3941.2025.0771)

Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment

PIK3CA mutations are key biomarkers for selecting phosphoinositide 3-kinase (PI3K)–targeted therapies in breast cancer, yet access to molecular testing can be inconsistent and costly. Conventional polymerase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.